Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teh-Ia Huo

Showing results (11-20 of 229) with videos related to

Pageof 23
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective studyTeh-Ia Huo, Jaw-Ching Wu, Pui-Ching Lee, et al.
Scandinavian Journal of Gastroenterology|March 28, 2002
Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapyTeh-Ia Huo, Yi-Hsiang Huang, Jaw-Ching Wu, et al.
World Journal of Surgery|March 8, 2013
Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteriaYun-Hsuan Lee, Cheng-Yuan Hsia, Chia-Yang Hsu, et al.
European Journal of Gastroenterology & Hepatology|June 16, 2004
Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiencyTeh-Ia Huo, Yi-Hsiang Huang, Jaw-Ching Wu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 16, 2014
Interleukin-1 receptor antagonist correlates with hepatic venous pressure gradient and predicts occurrence of overall complications and bacterial infections in patients with cirrhosisYun-Cheng Hsieh, Kuei-Chuan Lee, Ying-Ying Yang, et al.
Journal of the Chinese Medical Association : JCMA|December 14, 2023
Performance status as a prognostic surrogate in hepatocellular carcinoma: Role of albumin-bilirubin and easy-albumin-bilirubin gradeJia-I Liao, Shu-Yein Ho, Ming-Chih Hou, et al.
Journal of the Chinese Medical Association : JCMA|August 13, 2013
Induced pluripotent stem cells and hepatic differentiationChih-Hung Chiang, Teh-Ia Huo, Cho-Chin Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 8, 2025
Paracentesis exceeding three liters increases risks of acute kidney injury even in cirrhotic patients with albumin infused refractory ascitesPei-Shan Wu, Kuei-Chuan Lee, Chih-Yu Li, et al.
Journal of Clinical Gastroenterology|July 11, 2006
The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapyTeh-Ia Huo, Pui-Ching Lee, Yi-Hsiang Huang, et al.
Oncology Reports|January 14, 2004
Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single centerTeh-Ia Huo, Yi-Hsiang Huang, Wing-Yiu Lui, et al.
Pageof 23

Showing results (11-20 of 229) with videos related to

Sort By:
Pageof 23
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2004
Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective studyTeh-Ia Huo, Jaw-Ching Wu, Pui-Ching Lee, et al.
Scandinavian Journal of Gastroenterology|March 28, 2002
Survival benefit of cirrhotic patients with hepatocellular carcinoma treated by percutaneous ethanol injection as a salvage therapyTeh-Ia Huo, Yi-Hsiang Huang, Jaw-Ching Wu, et al.
World Journal of Surgery|March 8, 2013
Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteriaYun-Hsuan Lee, Cheng-Yuan Hsia, Chia-Yang Hsu, et al.
European Journal of Gastroenterology & Hepatology|June 16, 2004
Percutaneous injection therapy for hepatocellular carcinoma in patients with chronic renal insufficiencyTeh-Ia Huo, Yi-Hsiang Huang, Jaw-Ching Wu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 16, 2014
Interleukin-1 receptor antagonist correlates with hepatic venous pressure gradient and predicts occurrence of overall complications and bacterial infections in patients with cirrhosisYun-Cheng Hsieh, Kuei-Chuan Lee, Ying-Ying Yang, et al.
Journal of the Chinese Medical Association : JCMA|December 14, 2023
Performance status as a prognostic surrogate in hepatocellular carcinoma: Role of albumin-bilirubin and easy-albumin-bilirubin gradeJia-I Liao, Shu-Yein Ho, Ming-Chih Hou, et al.
Journal of the Chinese Medical Association : JCMA|August 13, 2013
Induced pluripotent stem cells and hepatic differentiationChih-Hung Chiang, Teh-Ia Huo, Cho-Chin Sun, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 8, 2025
Paracentesis exceeding three liters increases risks of acute kidney injury even in cirrhotic patients with albumin infused refractory ascitesPei-Shan Wu, Kuei-Chuan Lee, Chih-Yu Li, et al.
Journal of Clinical Gastroenterology|July 11, 2006
The sequential changes of the model for end-stage liver disease score correlate with the severity of liver cirrhosis in patients with hepatocellular carcinoma undergoing locoregional therapyTeh-Ia Huo, Pui-Ching Lee, Yi-Hsiang Huang, et al.
Oncology Reports|January 14, 2004
Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single centerTeh-Ia Huo, Yi-Hsiang Huang, Wing-Yiu Lui, et al.
Pageof 23